CHD9 Antikörper
Kurzübersicht für CHD9 Antikörper (ABIN7112757)
Target
Alle CHD9 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Verwendungszweck
- CHD9 antibody
-
Aufreinigung
- Immunogen affinity purified
-
Reinheit
- ≥95 % as determined by SDS-PAGE
-
Immunogen
- chromodomain helicase DNA binding protein 9
-
Isotyp
- IgG
-
-
-
-
Applikationshinweise
- WB: 1:500-1:2000, IHC: 1:20-1:200
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Buffer
- PBS with 0.02 % sodium azide and 50 % glycerol pH 7.3,
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Handhabung
- Avoid repeated freeze / thaw cycles.
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- -20°C for 12 months
-
Haltbarkeit
- 12 months
-
-
- CHD9 (Chromodomain Helicase DNA Binding Protein 9 (CHD9))
-
Andere Bezeichnung
- CHD9
-
Hintergrund
-
Synonyms: Chromodomain-helicase-DNA-binding protein 9 (CHD-9)|ATP-dependent helicase CHD9|Chromatin-related mesenchymal modulator (CReMM)|Chromatin-remodeling factor CHROM1|Kismet homolog 2|PPAR-alpha-interacting complex protein 320 kDa|Peroxisomal proliferator-activated receptor A-interacting complex 320 kDa protein|CHD9|KIAA0308|KISH2|PRIC320
Background: Acts as a transcriptional coactivator for PPARA and possibly other nuclear receptors. Proposed to be a ATP-dependent chromatin remodeling protein. Has DNA-dependent ATPase activity and binds to A/T-rich DNA. Associates with A/T-rich regulatory regions in promoters of genes that participate in the differentiation of progenitors during osteogenesis(By similarity).
-
Molekulargewicht
- 330 kDa
-
Gen-ID
- 80205
-
UniProt
- Q3L8U1
-
Pathways
- Regulation of Lipid Metabolism by PPARalpha
Target
-